Samsung Biologics Co Ltd
KRX:207940

Watchlist Manager
Samsung Biologics Co Ltd Logo
Samsung Biologics Co Ltd
KRX:207940
Watchlist
Price: 949 000 KRW
Market Cap: 67.5T KRW
Have any thoughts about
Samsung Biologics Co Ltd?
Write Note

Relative Value

The Relative Value of one Samsung Biologics Co Ltd stock under the Base Case scenario is 726 369.08 KRW. Compared to the current market price of 949 000 KRW, Samsung Biologics Co Ltd is Overvalued by 23%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
726 369.08 KRW
Overvaluation 23%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
80
vs Industry
12
Median 3Y
17.3
Median 5Y
30.4
Industry
4.1
Forward
15.2
vs History
80
vs Industry
5
Median 3Y
69.1
Median 5Y
115.3
Industry
32.7
Forward
64.9
vs History
93
vs Industry
12
Median 3Y
52.6
Median 5Y
82.8
Industry
22.1
vs History
vs Industry
0
Median 3Y
-129.7
Median 5Y
-128.6
Industry
33.6
vs History
65
vs Industry
16
Median 3Y
6.4
Median 5Y
6.9
Industry
2.6
vs History
79
vs Industry
12
Median 3Y
16.9
Median 5Y
30.1
Industry
3.9
Forward
15.1
vs History
79
vs Industry
9
Median 3Y
34.4
Median 5Y
65.9
Industry
8.6
vs History
82
vs Industry
10
Median 3Y
39.8
Median 5Y
69.7
Industry
18.5
Forward
36.7
vs History
76
vs Industry
6
Median 3Y
54.4
Median 5Y
85.7
Industry
23.7
Forward
50.1
vs History
92
vs Industry
12
Median 3Y
51.5
Median 5Y
81.5
Industry
21.4
vs History
46
vs Industry
6
Median 3Y
67.9
Median 5Y
60.5
Industry
28.8
vs History
63
vs Industry
20
Median 3Y
4.4
Median 5Y
5
Industry
2.4

Multiples Across Competitors

Competitors Multiples
Samsung Biologics Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Samsung Biologics Co Ltd
KRX:207940
67.5T KRW 15.5 64.2 34.7 50
US
PerkinElmer Inc
LSE:0KHE
1.2T USD 450.7 4 823 1 522 3 243.5
US
Thermo Fisher Scientific Inc
NYSE:TMO
200.9B USD 4.7 32.7 21.2 30.4
US
Danaher Corp
NYSE:DHR
165.5B USD 7.8 42.5 26.7 40.2
CH
Lonza Group AG
SIX:LONN
38.4B CHF 5.7 67 45.3 45.3
US
Agilent Technologies Inc
NYSE:A
38.4B USD 5.9 29.8 22.2 25.9
US
IQVIA Holdings Inc
NYSE:IQV
36.2B USD 2.4 25.7 14.2 21.6
US
Mettler-Toledo International Inc
NYSE:MTD
26.8B USD 7.1 33.6 24.1 26.9
US
West Pharmaceutical Services Inc
NYSE:WST
23.9B USD 8.3 47.8 32.1 40.3
CN
WuXi AppTec Co Ltd
SSE:603259
163.8B CNY 4.3 20.3 14.8 14.8
US
Waters Corp
NYSE:WAT
22B USD 7.6 35.3 22.5 27.6

See Also

Discover More
Back to Top